Just a moment...
www.fiercebiotech.com
Non catégorisé
Chutes & Ladders—Former Roche oncology head turns to Tubulis
Non catégorisé
Baby KJ scientist launches personalized CRISPR therapy startup
Non catégorisé
Quanterix nabs Illumina’s CCO as new leader, but Leerink warns of ‘significant lift’ needed for turnaround
Non catégorisé
Madrigal pays $50M for Pfizer MASH drug with eye on Rezdiffra combo potential
Non catégorisé
AirNexis takes flight with $200M, links up with China pharma for COPD asset in $955M biobucks deal
Non catégorisé
Orca rides $250M funding wave toward cancer cell therapy launch
Non catégorisé
3 new venture funds collect nearly $1B for biotech in US, EU
Non catégorisé
Illumina hires former NHGRI Director Eric Green as new chief medical officer
Non catégorisé
1st biotech IPO of 2026 sees Aktis bring in $318M via upsized offering
Non catégorisé
Roche returns to MediLink with promise of $570M near-term payments for another ADC
Non catégorisé
Parabilis rockets ahead with $305M series F to 'upend the status quo' with tumor drug
Non catégorisé
Lilly buys inflammation biotech Ventyx for $1.2B in wake of Parkinson's, CV readouts
Non catégorisé
Equipped with $160M series A, Alveus debuts into crowded obesity development landscape
Non catégorisé
Foresee offloads MMP-12 inhibitors in $584M deal, focuses on Camcevi's potential
Non catégorisé
J&J, Google venture arms line up to back protein degradation biotech EpiBiologics' $107M series B
Non catégorisé
Lexeo Therapeutics, J&J team up to test heart pump technology for cardiac gene therapy delivery
Non catégorisé
Flagship-founded Tessera plans to lay off 90 employees in March
Non catégorisé
GSK inks a model deal in $50M bet on Noetik's cancer AI platform
Non catégorisé
Startup Spiro Medical snares $67M in series A funding for asthma treatment
Non catégorisé
Quest, Labcorp add fully at-home STI test to women’s health offerings
Non catégorisé
Longtime Charles River leader Jim Foster to retire, with COO set to take the helm
Non catégorisé
Ollin eyes phase 3 after bispecific tops Vabysmo in early-stage trial, clearing more retinal disease faster
Non catégorisé
Immuneering touts 64% 1-year survival, keeping wheels turning in race with Revolution
Non catégorisé
Innovation isn't enough: Biopharma needs urgent reinvention, PwC says
Non catégorisé
Diagonal moves forward with $125M series B round, plots first-in-human study this year
Non catégorisé
GSK's 'functional cure' for hep B proves worth in phase 3 trials setting up approval push
Non catégorisé
Basilea pens collab with US biotech to develop new antifungal
Non catégorisé
Staar Surgical's takeover saga ends as shareholder revolt stops Alcon’s attempted merger deal
Non catégorisé
Soley secures $200M series C to push AML cell stress drug into clinic
Non catégorisé
Rakuten lights path to 2028 FDA filing with fresh $100M raise
Non catégorisé
Fierce Biotech Fundraising Tracker '26: Soley sees $200M series C; Rakuten rakes in $100M
Non catégorisé
Pulmocide calls curtains on phase 3 antifungal trial over low response, higher mortality rate
Non catégorisé
Gilead study finds HIV can evolve to resist lenacapavir, but doing so hampers the virus' replication
Non catégorisé
WEP Clinical grabs European CRO Siron Clinical, broadening global capabilities
Non catégorisé
Lilly links up with InduPro in next-gen cancer treatment deal worth up to $950M
Non catégorisé
Hutchmed heats up autoimmune race with phase 3 win, teeing up China filing
Non catégorisé
FDA cites severe liver injury risk, unclear benefit behind Sanofi's MS drug rejection
Non catégorisé
UK biotech eyes $1B deal to enable eye gene therapy to be delivered in doctors' offices
Non catégorisé
Gilead garners lipid package for cancer asset in $300M research pact
Non catégorisé
Pfizer charts course to tumor-selective antigens in $865M Cartography collab
Non catégorisé
Instil's stock sinks after it clears out pipeline, hands 2 drugs back to ImmuneOnco
Non catégorisé
Alumis beams as pivotal data on Sotyktu rival drive stock surge
Non catégorisé
Naox Technologies nabs 1st FDA clearance for in-ear EEG brain monitoring device
Non catégorisé
Lilly returns to Nimbus with $1.3B deal to create new oral obesity drug
Non catégorisé
Arrowhead takes aim at obesity market with early data on dual gene silencing assets
Non catégorisé
In Structure licensing deal, Roche commits $100M to shore up GLP-1 position
Non catégorisé
Amgen stitches new acquisition worth up to $840M for UK biotech and its cancer programs
Non catégorisé
Bright Minds shines with phase 2 win for anti-seizure serotonin receptor activator
Non catégorisé